Global Point of Care

Testing is the best way to monitor heart health

World Heart Day 2021

This World Heart Day serves as a reminder for your patients to be proactive
in their heart health. 

Your patients' chances of developing cardiovascular diseases can be greatly reduced by establishing good habits. Encourage them to be active, keep their weight and blood pressure under control, avoid tobacco, eat a heart-healthy diet, and take the time to learn about cholesterol, blood sugar and diabetes.1,2

For those living with chronic diseases and conditions, such as Cardiovascular Disease, today's pandemic poses risks beyond developing the coronavirus disease. Studies show patients with chronic conditions during this time are delaying care which could lead to complications.3

In a US based survey of patients who regularly visit their physician, 33% of cardiology and 47% of endocrinology patients mentioned they’re likely going to postpone/cancel their appointments for endo/cardio.4 At the same time, these patients identified several lifestyle changes, such as exercising less, eating more, and more time spent inside, which all present a rising concern for the management of CVD risks.5

Of course, family history and age play a role as well. For example, postmenopausal women have a higher risk for heart disease as their bodies' production of estrogen drops.6 The best way of assessing risk is routinely testing your patients for high blood pressure, high cholesterol, and diabetes7 — and to control their numbers over time. 


Rapid diagnostic solutions to help you fight CVD

It’s believed that the two most common predictors for CVD are atherosclerosis and hypertension. Counseling and medicines can treat both risk factors — reducing the probability of the condition recurring or worsening, and prevent future complications.

Elevated cholesterol is one of the major risk factors for coronary heart disease, heart attack and stroke. As the blood cholesterol rises, so does the cardiovascular disease risk. Many patients, such as those with metabolic syndrome, have comorbid conditions such as high lipids and diabetes. And if other risk factors are present such as smoking, high blood pressure or diabetes, the risk increases even further.

The first step is an accurate diagnosis. Early detection is essential to cardiac care. At Abbott, we offer comprehensive cardiac solutions that are a natural fit for a wide range of outpatient settings – including physician offices, clinics, community health center, hospital and long-term care facilities, emergency rooms, and hospital outpatient clinics. Our assays and analyzers provide accurate, reliable results with rapid turnaround time, aiding clinicians in providing better patient care. 

Guidelines around the world support measuring a fasting or nonfasting Lipid Panel/Cholesterol every five years in healthy adults, more regularly if you have other risk factors, in children and youths who are at an increased risk and to evaluate the success of lipid-lowering treatment.11,12,13,14

Both the Cholestech LDX™ System and the Afinion™ Lipid Panel (sold outside of the United States only) offer point-of-care testing for cholesterol and related lipids to serve as diagnostic tools that provide information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes.

Related Products

Cholestech LDX™ System

Accurate, actionable results from the leader in point-of-care lipid testing.

The CLIA-waived Cholestech LDX™ System helps monitor your at-risk patients. Engineered for confidence, this analyzer provides accurate, actionable, and readily accessible results for point-of-care lipid profile, cholesterol, and glucose testing.

1.  World Heart Federation. The link between COVID-19 and CVD. Accessed 7/22/2020.

2.  Benjamin EJ, Blaha MJ, Chiuve E et al. Heart Disease and Stroke Statistics—2017 Update. A Report From the American Heart Association. Circulation. 2017 Mar 7; 135(10): e146–e603.

3.  Findling MG, Blendon RJ, Benson JM. Delayed Care with Harmful Health Consequences—Reported Experiences from National Surveys During Coronavirus Disease 2019. JAMA Health Forum. 2020;1(12):e201463. doi:10.1001/jamahealthforum.2020.1463.

4.  M/A/R/C Research COVID-19’s Impact on Healthcare Attitudes and Practices - Wave 2 (May 2020)

5.  M/A/R/C Research COVID-19’s Impact on Healthcare Attitudes and Practices - Wave 2 (May 2020)

6.  National Heart, Lung, and Blood Institute. Listen to Your Heart: Learn About Heart Disease. Accessed August 28th 2020

7.  World Health Organisation (WHO). What can I do to avoid a heart attack or a stroke? Accessed August 28th 2020

8.  World Health Organization (WHO). 10 Facts on Noncommunicable Diseases. Accessed August 28th 2020

9.  ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal (2013) 34, 3035-3087

10. World Health Organisation (WHO). The challenge of cardiovascular disease – quick statistics. Http:// Accessed Agust 28th 2020

11.  Gooding HC, Ferranti SD. Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter. Curr Opin Pediatr. 2010 Aug; 22(4): 398–404.

12.  American Heart Association (AHA). How often should cholesterol be checked? Accessed Agust 28th 2020

13.  HEART UK The Cholesterol Charity. Getting a cholesterol test.. Accessed August 28th 2020

14.  American Diabetes Association (ADA). Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43(1)